Literature DB >> 22549770

Behavioral symptoms in mild cognitive impairment as compared with Alzheimer's disease and healthy older adults.

Stefan Van der Mussele1, Nathalie Le Bastard, Yannick Vermeiren, Jos Saerens, Nore Somers, Peter Mariën, Johan Goeman, Peter P De Deyn, Sebastiaan Engelborghs.   

Abstract

BACKGROUND: Mild cognitive impairment (MCI) is a clinical concept that categorizes subjects who are in an intermediate cognitive state between normal aging and dementia. The aim of this study is to characterize behavior in MCI compared with Alzheimer's disease (AD) and healthy older patients.
DESIGN: A cross-sectional analysis of baseline data from a prospective, longitudinal study on behavioral symptoms of dementia and MCI was performed. The study population consisted of 270 MCI, 402 AD patients, and 108 healthy controls. Behavioral assessment was performed by means of Middelheim Frontality Score, Behavioral Pathology in Alzheimer's Disease Rating Scale, Cohen-Mansfield Agitation Inventory, and Cornell Scale for Depression in Dementia.
RESULTS: Moderate-to-severe behavioral symptoms were present in 13% of MCI patients, as compared with 39% in AD patients and 3% in controls (p < 0.001). The general severity of behavioral symptoms was intermediate between controls and AD patients. The three most frequent symptoms in MCI patients were aggressiveness (49%), affective disturbance (45%), and anxiety (38%); in AD patients, the most frequent symptoms were aggressiveness (60%), activity disturbances (54%), and psychosis (40%). The prevalence and severity of frontal lobe symptoms, aggressiveness, activity disturbances, and delusions was intermediate between normal aging and AD. In addition, the severity of physically non-aggressive and verbally agitated behavior and the severity of depressive symptoms were also intermediate.
CONCLUSIONS: The behavioral profile of MCI patients is characterized as an intermediate state between normal aging and AD for the prevalence and severity of certain behavioral symptoms. Follow-up is ongoing to test the hypothesis that behavioral disturbances in MCI predict progression to dementia.
Copyright © 2012 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2012        PMID: 22549770     DOI: 10.1002/gps.3820

Source DB:  PubMed          Journal:  Int J Geriatr Psychiatry        ISSN: 0885-6230            Impact factor:   3.485


  8 in total

1.  Skin Conduction Levels Differentiate Frontotemporal Dementia From Alzheimer's Disease.

Authors:  Mario F Mendez; Sylvia S Fong; Mark M Ashla; Elvira E Jimenez; Andrew R Carr
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2018-04-06       Impact factor: 2.198

Review 2.  Clinical workout for the early detection of cognitive decline and dementia.

Authors:  M Tsolaki
Journal:  Eur J Clin Nutr       Date:  2014-10-01       Impact factor: 4.016

3.  Effects of brain-derived neurotrophic factor-pretreated neuron stem cell transplantation on Alzheimer's disease model mice.

Authors:  Tong Li; Ying Yu; Hongliu Cai
Journal:  Int J Clin Exp Med       Date:  2015-11-15

4.  Delusions in Patients with Dementia with Lewy Bodies and the Associated Factors.

Authors:  Ray-Chang Tzeng; Ching-Fang Tsai; Ching-Tsu Wang; Tzu-Yuan Wang; Pai-Yi Chiu
Journal:  Behav Neurol       Date:  2018-05-07       Impact factor: 3.342

5.  Association between the instrumented timed up and go test and cognitive function, fear of falling and quality of life in community dwelling people with dementia.

Authors:  Jonathan M Williams; Samuel R Nyman
Journal:  J Frailty Sarcopenia Falls       Date:  2018-12-01

Review 6.  The Relationship Between Anxiety and Alzheimer's Disease.

Authors:  Mario F Menddez
Journal:  J Alzheimers Dis Rep       Date:  2021-03-08

7.  Benzodiazepine use and risk of Alzheimer's disease: case-control study.

Authors:  Sophie Billioti de Gage; Yola Moride; Thierry Ducruet; Tobias Kurth; Hélène Verdoux; Marie Tournier; Antoine Pariente; Bernard Bégaud
Journal:  BMJ       Date:  2014-09-09

8.  Phenotypic characteristics of Alzheimer patients carrying an ABCA7 mutation.

Authors:  Tobi Van den Bossche; Kristel Sleegers; Elise Cuyvers; Sebastiaan Engelborghs; Anne Sieben; Arne De Roeck; Caroline Van Cauwenberghe; Steven Vermeulen; Marleen Van den Broeck; Annelies Laureys; Karin Peeters; Maria Mattheijssens; Mathieu Vandenbulcke; Rik Vandenberghe; Jean-Jacques Martin; Peter P De Deyn; Patrick Cras; Christine Van Broeckhoven
Journal:  Neurology       Date:  2016-04-01       Impact factor: 9.910

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.